Öz
Aim: In this study, we aimed to reveal the frequency of vaccination hesitations in the parents of individuals aged 12-18 years children with allergic disease and the possible reasons for this.
Material and methods: In this prospective study, patients admitted with the diagnosis of allergic conjunctivitis, allergic rhinoconjunctivitis, allergic asthma, atopic eczema, chronic idiopathic urticaria and food allergy between February 2022 and July 2022 were included. A total of 72 children with allergic diseases were evaluated.
Results: 36.1% (n=26) of the patients included in the study were girls. The mean age was 14.2±1.6 years. The mean absolute eosinophil count of the patients was 277.5±208.9 / mm3, the mean total IgE level was 139.7±137.2 / kU/L. According to their diseases, 13 cases of asthma, 22 cases of allergic rhinoconjunctivitis, 8 cases of both allergic rhinitis and asthma, 10 cases of atopic eczema, 13 cases of chronic idiopathic urticaria, and 6 cases of food allergy were diagnosed. 52.8% (n=38) of the patients were vaccinated for COVID-19. At least 2 doses of COVID-19 vaccine were administered to all vaccinated cases.
Conclusion: The vaccination rate for COVID-19 in children with respiratory allergic diseases such as allergic rhinoconjunctivitis and allergic asthma is higher than in cases followed up with other allergic disease diagnoses. In most of the parents of patients with atopic eczema, chronic idiopathic urticaria, and food allergy, COVID-19 vaccine hesitancy was detected.
The presence of allergic disease was determined as the reason for not being vaccinated.
Anahtar Kelimeler
Kaynakça
- 1. Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961.
- 2. Simon D. Recent Advances in Clinical Allergy and Immunology 2019. Int Arch Allergy Immunol. 2019;180(4):291-305.
- 3. Ozturk AB, Baççıoğlu A, Soyer O, Civelek E, Şekerel BE, Bavbek S. Change in Allergy Practice during the COVID-19 Pandemic. Int Arch Allergy Immunol. 2021;182(1):49-52.
- 4. Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review. Front Public Health. 2021 Aug 13;9:698111. doi: 10.3389/fpubh.2021.698111. PMID: 34485229; PMCID: PMC8414566.
- 5. Bellanti JA. COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance. Allergy Asthma Proc. 2021 Sep 9;42(5):386-394.
- 6. Cruz C, Gaspar Â, Borrego LM. Allergic Reactions to COVID-19 Vaccines: An Allergist's Perspective. Acta Med Port. 2021 Mar 1;34(3):243.
- 7. Olusanya OA, Bednarczyk RA, Davis RL, Shaban-Nejad A. Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic. Front Immunol. 2021 Mar 18;12:663074.
- 8. Hudson A, Montelpare WJ. Predictors of Vaccine Hesitancy: Implications for COVID-19 Public Health Messaging. Int J Environ Res Public Health. 2021 Jul 29;18(15):8054. doi: 10.3390/ijerph18158054. PMID: 34360345; PMCID: PMC8345367.
- 9. Risma KA. COVID-19 mRNA vaccine allergy. Curr Opin Pediatr. 2021 Dec 1;33(6):610-617. doi: 10.1097/MOP.0000000000001077. PMID: 34670264; PMCID: PMC8577302.
- 10. Kwok KO, Li KK, Wei WI, Tang A, Wong SYS, Lee SS. Editor's Choice: Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey. Int J Nurs Stud. 2021 Feb;114:103854.
- 11. Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health (Oxf). 2021 Sep 22;43(3):445-449
- 12. Coustasse A, Kimble C, Maxik K. COVID-19 and Vaccine Hesitancy: A Challenge the United States Must Overcome. J Ambul Care Manage. 2021 Jan/Mar;44(1):71-75.
Öz
Amaç: Bu çalışmamızda 12-18 yaş arası alerjik hastalığı olan bireylerin ebeveynlerindeki aşı kararsızlığı sıklığını ve bunun olası sebeplerini ortaya koymayı amaçladık.
Gereç ve yöntem: Prospektif olan bu çalışmaya Şubat 2022 - Temmuz 2022 tarihleri arasında alerjik konjonktivit, alerjik rinokonjoktivit, alerjik astım, atopik egzema, kronik idiopatik ürtiker ve besin alerjisi tanılarıyla başvuran hastalar dahil edildi. Toplam 72 alerjik hastalığı olan çocuk değerlendirildi.
Bulgular: Çalışmaya alınan hastaların %36,1’ i (n=26) kız idi. Ortalama yaş 14,2±1,6 saptandı. Hastaların ortalama mutlak eozinofil sayısı 277,5±208,9 / mm3, ortalama total IgE düzeyi 139,7±137,2 / kU/L olarak hesaplandı. Hastalıklarına göre 13 olgu astım, 22 olgu alerjik rinokonjoktivit, 8 olgu hem alerjik rinit hem astım, 10 olgu atopik egzema, 13 olgu kronik idiopatik ürtiker, 6 olgu besin alerjisi tanısı almıştı. Hastaların %52,8’i (n=38) COVİD-19 için aşılanmıştı. Aşılanan tüm olgulara en az 2 doz COVİD-19 aşısı uygulanmıştı.
Sonuç: Alerjik rinokonjoktivit, alerjik astım gibi solunum yolu alerjik hastalık tanılı çocukların COVİD-19’ a karşı aşılanma oranı, diğer alerjik hastalık tanıları ile izlenen olgulara göre daha yüksektir. Atopik egzema, kronik idiopatik ürtiker, besin alerjisi olan hasta ebeveynlerinin büyük çoğunluğunda COVİD-19 aşı karasızlığı saptanmıştır. Aşılanmama nedeni olarak da alerjik hastalık varlığı tespit edilmiştir.
Anahtar Kelimeler
Kaynakça
- 1. Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China. PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961.
- 2. Simon D. Recent Advances in Clinical Allergy and Immunology 2019. Int Arch Allergy Immunol. 2019;180(4):291-305.
- 3. Ozturk AB, Baççıoğlu A, Soyer O, Civelek E, Şekerel BE, Bavbek S. Change in Allergy Practice during the COVID-19 Pandemic. Int Arch Allergy Immunol. 2021;182(1):49-52.
- 4. Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review. Front Public Health. 2021 Aug 13;9:698111. doi: 10.3389/fpubh.2021.698111. PMID: 34485229; PMCID: PMC8414566.
- 5. Bellanti JA. COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance. Allergy Asthma Proc. 2021 Sep 9;42(5):386-394.
- 6. Cruz C, Gaspar Â, Borrego LM. Allergic Reactions to COVID-19 Vaccines: An Allergist's Perspective. Acta Med Port. 2021 Mar 1;34(3):243.
- 7. Olusanya OA, Bednarczyk RA, Davis RL, Shaban-Nejad A. Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic. Front Immunol. 2021 Mar 18;12:663074.
- 8. Hudson A, Montelpare WJ. Predictors of Vaccine Hesitancy: Implications for COVID-19 Public Health Messaging. Int J Environ Res Public Health. 2021 Jul 29;18(15):8054. doi: 10.3390/ijerph18158054. PMID: 34360345; PMCID: PMC8345367.
- 9. Risma KA. COVID-19 mRNA vaccine allergy. Curr Opin Pediatr. 2021 Dec 1;33(6):610-617. doi: 10.1097/MOP.0000000000001077. PMID: 34670264; PMCID: PMC8577302.
- 10. Kwok KO, Li KK, Wei WI, Tang A, Wong SYS, Lee SS. Editor's Choice: Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey. Int J Nurs Stud. 2021 Feb;114:103854.
- 11. Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health (Oxf). 2021 Sep 22;43(3):445-449
- 12. Coustasse A, Kimble C, Maxik K. COVID-19 and Vaccine Hesitancy: A Challenge the United States Must Overcome. J Ambul Care Manage. 2021 Jan/Mar;44(1):71-75.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Konular | Çocuk İmmünolojisi ve Alerji Hastalıkları |
| Bölüm | Araştırma Makaleleri |
| Yazarlar | |
| Yayımlanma Tarihi | 12 Haziran 2023 |
| Gönderilme Tarihi | 18 Temmuz 2022 |
| Yayımlandığı Sayı | Yıl 2023Cilt: 62 Sayı: 2 |
